CTC Electrotrichogenesis (ETG) Mark 1

Země: Singapur

Jazyk: angličtina

Zdroj: HSA (Health Sciences Authority)

Dostupné s:

Gromark Consumers Enterprise Pte Ltd

Třída:

Class B medical device

Výrobce:

Current Technology Corporation

Terapeutické oblasti:

General Hospital

Terapeutické indikace:

ETG is intended to stabilize hair loss and stimulates hair regrowth in those suffering from common baldness using pulsed electrical stimulation. ETG is indicated in mild to moderate cases of balding where no other pathology is present. The typical pattern in males shows an initial receding hairline and thinning on the crown of the head, with the two areas eventually joining together. In female, the pattern is a general but diffuse loss extending from the frontoparietal area throughout the crown. Complete alopecia (totalis) is unlikely to be impacted by ETG therapy as hair follicles are absent.

Přehled produktů:

Models: CTC Electrotrichogenesis (ETG) Mark 1 - -

Datum autorizace:

2005-01-11